BioEthics Advantage Competitors

In the era of accountability, expectations for businesses to do right is not just about legal consequence. It’s about cascading, value realization: higher stock value, employee retention, consumer preference and overall brand recognition. And we’ve been tracking this value for 18 years – it’s called the Ethisphere’s Ethics Premium. Ethisphere is the premiere partner for ethical acceleration so you can realize your business’s potential by tapping into the compounding value of doing business with integrity. Ethisphere brings together community, data and expertise. We co-create standards with and for our partners, innovate ethical best-practices and then implement change with our suite of tools fueled by data and expertise. Together, we expand your influence so you can build a legacy grounded in ethical business practices.

Bioethics International is a 501(c)(3) public charity, founded in 2005, to strengthen ethics, transparency, trust, and patient-centricity in healthcare. We turn core bioethics principles into practical, evidence-based standards that guide, evaluate, and improve how healthcare and life science companies operate across the full medicine lifecycle—from clinical trials to patient access. Through public benchmarking, stakeholder collaboration, and ethical persuasion, we equip industry leaders, policymakers, investors, patients, and the public with tools to align business practices with the highest ethical standards—ensuring that patient health, dignity, and trust remain at the center of innovation. ✨The Good Pharma Scorecard (GPS), is a central initiative, an annual ranking of pharmaceutical companies on their bioethical performance. The Scorecard sets clear, evidence-based benchmarks for what “good” looks like in patient-centered healthcare. We then evaluate and rank company performance, spotlighting leaders, catalyzing reform where it’s needed, and tracking progress over time. The Good Pharma Scorecard drives accountability and improvement by making ethical performance visible, measurable, and competitive—encouraging companies to lead not only in science, but also in responsibility to patients. The impact is clear: industry-wide transparency scores have risen each year. In one example, half of the lower-scoring companies in 2019 improved their data-sharing practices within 30 days of receiving their Scorecard results. Companies display their GPS Leaderboard badges in CEO letters, annual reports, and SEC filings. Building on momentum, BEI launched the Bioethics Leadership Forum, an invited community of leaders across academia, industry, patients, healthcare, policy, and investment to support our mission. ✨ Together, we are redefining what ethical leadership looks like, ensure progress in science is matched by progress in trust and patient centricity.

Established in 1995, the Berman Institute now consists of more than 35 faculty from the Johns Hopkins School of Medicine, School of Nursing, Bloomberg School of Public Health, Paul H. Nitze School of Advanced International Studies and the Krieger School of Arts and Sciences. Faculty work collaboratively across the Institute’s program areas. Our Vision is to achieve more ethical practices and policies relevant to human health. Our Mission is to identify and address key ethical issues in science, clinical care, and public health, locally and globally. Areas in which we work Core Programs Public Health Ethics Clinical Ethics Science Ethics Cross-Cutting Programs Research Ethics Global Bioethics Education/Training Programs The Berman Institute trains and mentors future leaders in the fields of bioethics, health and science through the Master of Bioethics (MBE) Program; the PhD concentration in bioethics and health policy; the Hecht-Levi Fellowship program; the Johns Hopkins-Fogarty African Bioethics Training Program; the Arts and Sciences minor in bioethics; the bioethics certificate; and intensive courses in bioethics. The Berman Institute also provides policy advice for government agencies, non-governmental organizations, and private sector organizations. Institute Leadership Jeffrey Kahn, PhD, MPH, Andreas C Dracopoulos Director Nancy Kass, ScD, Deputy Director for Public Health Jeremy Sugarman, MD, MPH, MA, Deputy Director for Medicine